Thomas A. Dix

Corporate Officer/Principal presso Medical University of South Carolina

Consumer Services

Health Technology

Profilo

Thomas A.
Dix is a Director and Chief Scientific Officer of Argolyn Bioscience, Inc. He is an Associate Professor of Pharmaceutical Sciences in the College of Pharmacy at the Medical University of South Carolina.
Previously, he was an Assistant Professor in the Departments of Chemistry and Biological Chemistry at the University of California, Irvine.
Dr. Dix received a PhD in Chemistry from Wayne State University.

Posizioni attive di Thomas A. Dix

Società	Posizione	Inizio
Medical University of South Carolina	Corporate Officer/Principal	27/05/2009

Tutte le posizioni attive di Thomas A. Dix

Precedenti posizioni note di Thomas A. Dix

Società	Posizione	Fine
Argolyn Bioscience, Inc. Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC.	Fondatore	26/11/2009
University of California, Irvine	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Thomas A. Dix

Formazione di Thomas A. Dix

Wayne State University (Michigan)	Doctorate Degree
The Pennsylvania State University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas A. Dix

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Argolyn Bioscience, Inc. Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC.	Health Technology